TITLE:
A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.

CONDITION:
Breast Neoplasms

INTERVENTION:
SU011248

SUMMARY:

      Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who
      have failed selected other therapies.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Anthracycline and taxane-refractory or intolerant metastatic breast cancer

          -  Female

        Exclusion Criteria:

          -  Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic
             disease setting beyond those containing anthracyclines/taxanes.
      
